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Abstract
Background: The cause of the bovine spongiform encephalopathy (BSE) epidemic in the United
Kingdom (UK) was the inclusion of contaminated meat and bone meal in the protein rations fed to
cattle. Those rations were not restricted to cattle but were also fed to other livestock including
farmed and free living deer. Although there are no reported cases to date of natural BSE in
European deer, BSE has been shown to be naturally or experimentally transmissible to a wide range
of different ungulate species. Moreover, several species of North America's cervids are highly
susceptible to chronic wasting disease (CWD), a transmissible spongiform encephalopathy (TSE)
that has become endemic. Should BSE infection have been introduced into the UK deer population,
the CWD precedent could suggest that there is a danger for spread and maintenance of the disease
in both free living and captive UK deer populations. This study compares the immunohistochemical
and biochemical characteristics of BSE and CWD in experimentally-infected European red deer
(Cervus elpahus elaphus).
Results: After intracerebral or alimentary challenge, BSE in red deer more closely resembled
natural infection in cattle rather than experimental BSE in small ruminants, due to the lack of
accumulation of abnormal PrP in lymphoid tissues. In this respect it was different from CWD, and
although the neuropathological features of both diseases were similar, BSE could be clearly
differentiated from CWD by immunohistochemical and Western blotting methods currently in
routine use.
Conclusion: Red deer are susceptible to both BSE and CWD infection, but the resulting disease
phenotypes are distinct and clearly distinguishable.
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Background
Bovine spongiform encephalopathy (BSE) is one of a
group of transmissible spongiform encephalopathies
(TSEs), which include Creutzfeldt-Jakob disease in
humans, chronic wasting disease (CWD) in deer and
scrapie in sheep and goats. These invariably fatal neuro-
degenerative disorders typically show lesions such as
spongiform change, gliosis and deposition of the disease-
associated form (PrPd) of the normal cellular prion pro-
tein (PrPc).
Contaminated meat and bone meal (MBM) within con-
centrated rations fed to cattle was the cause of the BSE epi-
demic in the United Kingdom (UK [1]) and elsewhere in
Europe. Exotic ungulates were also exposed to this mate-
rial resulting in cases of BSE in zoological collections
[2,3], and it is likely that cervids in these collections were
also exposed [4]. Similarly, contaminated rations could
have also been fed to farmed and free ranging deer, the lat-
ter as a winter supplement. In March 2007, the European
Union adopted a Commission Decision calling for a sur-
vey for TSEs in cervid populations, and monitoring of
farmed and wild red deer began in the UK. Despite there
not being any reported cases so far, the possibility that
BSE infection occurred in deer prior to MBM bans cannot
be ruled out as, on the other hand, several deer species are
affected by CWD. One of those species is the elk or wapiti
(Cervus elaphus nelsoni), which is closely related to the red
deer (Cervus elaphus elaphus), the most frequently farmed
cervid in the UK. Unlike other TSEs, CWD is the only TSE
that is maintained in free-ranging animals with low pop-
ulation densities (2–3 deer per square mile), and surveil-
lance data suggests an increasing prevalence of infection
[5]. It is highly transmissible by natural routes of infec-
tion, so that the prevalence of infection can reach 100% in
farmed herds [6], perhaps also influenced by the fact that,
unlike sheep with scrapie, deer appear not to have any
absolute genetic resistance to CWD [7].
Should BSE infection have been introduced to the UK red
deer population, both the stability of the BSE agent
through the species barriers and the high transmissibility
of CWD, could account for spread and maintenance of
BSE in free-living and captive UK deer. Due to the poten-
tial risk for human health from the consumption of con-
taminated deer products, it was deemed appropriate to
determine the susceptibility or resistance of UK red deer to
BSE and, if susceptible, to characterize the resulting dis-
ease phenotype in comparison with that of CWD in the
same subspecies.
We previously described the susceptibility of UK red deer
to BSE infection by intracerebral injection [8], and the
present paper deals mainly with the comparative immu-
nohistochemical (IHC) and Western blot (WB) features of
experimental BSE and CWD infections in red deer. In
addition, proof of concept is given that red deer are also
susceptible to BSE by the oral route, albeit at high dose
and apparently with a low attack rate and extended incu-
bation period. In doing the experiments described here,
we have also accrued a bank of positive control material
to help future research and to be used as reference in the
surveillance for BSE in red deer.
Methods
Experimental procedures
BSE experiments
Six one year-old red deer were intra-cerebrally (i.c.) inoc-
ulated with 0.5 ml of a 10% homogenate of a brain pool
of five BSE-positive bovine brains (BBP12/92); this exper-
iment has already been described [8]. A further six red
deer aged 4 weeks were orally dosed via stomach tube
with 25 g of another cattle BSE brain pool homogenate
containing 103.5 RIII mouse (i.c./intraperiotoneal) units
ID50/g; as with the BSE inoculum for i.c. challenge, this
one also was provided by the TSE archive at VLA-Wey-
bridge. Two and four negative control animals underwent
identical procedures to the i.c and orally dosed deer,
respectively, with sterile normal saline instead of brain
homogenate. All experimental animal procedures were
approved by the Moredun Research Institute Animal
Experiments Ethical Committee and authorised under the
UK Animals (Scientific Procedures) Act 1986.
CWD experiment
This was carried out by the Canadian Food Inspection
Agency (Ottawa, Canada). Four European red deer were
challenged with 5 g of a pooled brain homogenate from
four elk with clinical CWD. The inoculum was adminis-
tered in three doses three days apart and although it was
not titrated, it gave an optical density reading of >3.5
(upper limit of measurement) in the Bio-Rad TsSeE test.
Disease monitoring, post-mortems and tissue sampling
Deer challenged with BSE were clinically monitored daily
and weighed monthly, until they reached a clinical end
point established at the beginning of the experiment, as
previously described [8]. After discussion and agreement,
a similar approach was applied to CWD inoculated red
deer. Biopsies of rectal mucosa were sequentially taken
during the incubation period of both BSE and CWD inoc-
ulated animals; rectal biopsies may be used for pre-clini-
cal diagnosis of TSEs in sheep [9] and in deer [10]. Deer
were killed by barbiturate overdose and exsanguination.
At post-mortem, an extensive range of tissue samples was
taken and fixed in 10% neutral buffered formalin or fro-
zen and stored at -80°C.
Histopathology and IHC
Fixed samples were post-fixed in fresh 10% neutral buff-
ered formalin and routinely processed for embedding in
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after staining with haematoxylin and eosin or immunola-
belling for PrPd. The tissues examined by IHC from BSE
inoculated deer have been described in detail previously
[8], and included samples from the central and peripheral
nervous systems, lymphoreticular system (LRS), and sev-
eral other tissues. From CWD inoculated deer, eight brain
areas and the medial retropharyngeal lymph node were
available for IHC examinations.
The IHC method has been detailed elsewhere [11,12].
Briefly, tissue sections were subjected to antigen retrieval,
peroxidase quenching and blocking of non-specific anti-
gens prior to incubation with the primary antibody. This
was carried out overnight at 27°C, and the subsequent
steps of the IHC protocol were performed by a commer-
cial immunoperoxidase technique (Vector-elite ABC kit;
Vector Laboratories, Peterborough, UK) and finally coun-
terstained with Mayer's haematoxylin. PrP primary anti-
bodies used were BAR224 (CEA, Saclay, France), which
recognizes amino acid residues (aa) 141–147 of ovine PrP
[13], and 12B2 (CIDC, Lelystad, The Netherlands), recog-
nizing aa 93–97 of ovine PrP [14]. Both antibodies have
wide inter-species reactivity and were selected as the most
specific and sensitive from a panel of antibodies tested
against CWD positive and negative deer control tissues at
the outset of the study.
Western blot
Samples of medulla oblongata from BSE and CWD inoc-
ulated deer developing clinical disease and from non-
inoculated controls were processed using the BioRad
TeSeE universal WB, following the kit instructions. Briefly,
350 mg of tissue were ribolysed, purified, treated with
proteinase K, and PrPres-concentrated. After heating, 20
mg equivalent of samples were loaded in duplicate lanes
onto pre-cast 12% bis-tris gels (Bio-Rad laboratories Ltd.
Bio-Rad House, Maxted Road, Hemel Hempstead, Hert-
fordshire, HP2 7DX.), and subjected to electrophoresis.
The proteins were then transferred onto PVDF mem-
branes, blocked (Bio-Rad blocking solution) and probed
for 30 mins at room temperature with each of a panel of
five antibodies: 6H4 (aa 156–164 [15]), F99 (aa 229–232
[16]), Sha31 (aa 156–163 [17]), P4 (aa 93–99 [18]), and
12B2. After washing, the membranes were incubated with
the secondary antibody at room temperature, and with
ECL substrate (Amersham Biosciences UK limited) for 45
s – 1 min, and the signal was detected with the Fluor-S
MultiImager (Bio-Rad, Maxted Road Hemel Hempstead
Hertfordshire HP2 7DX, UK).
The blots were assessed for molecular weights and propor-
tions of the three PrPres bands, and for the affinities for
each PrP antibody. For comparison, brain samples from
CWD positive and negative elk, BSE positive cattle and
scrapie positive sheep were used.
Discriminatory and scoring methods
The IHC "epitope mapping" and "PrPd profiling", and the
discriminatory WB allow differentiation between sheep
BSE and natural and experimental scrapie in sheep and in
other species. The IHC "epitope mapping" and the dis-
criminatory WB are based on the availability of specific
epitopes on PrPd subjected to enzymatic attack "in vivo"
(in intracellular lysosomes) and "in vitro" (by protease
digestion), respectively [19,20]. It has been hypothesized
that in experimental ovine BSE, epitopes between amino
acids 93 and 97 of the PrP sequence are absent after enzy-
matic digestion, as truncation of the protein occurs further
towards the C terminus, and therefore, these truncated
forms of PrPd are not labelled by 12B2 or P4. In contrast,
in CWD and scrapie, the PrPd molecule is truncated fur-
ther towards the N terminus and the labelling with those
antibodies is maintained after "in vivo" or "in vitro" diges-
tion. "PrPd profiling" is the most sophisticated technique
for IHC strain differentiation: using a single antibody
directed at the globular or C-terminal domains of the pro-
tein, this approach entails the subjective scoring (0–3) of
different PrPd types (intra-cellular, cell membrane bound
and extracellular) across different areas of the brain to
produce a graphic profile, which is representative of the
IHC phenotype [11,12].
Results
Clinical disease
All six deer challenged i.c. with BSE developed clinical dis-
ease between 794 and 1260 days post-inoculation with a
mean incubation period of 1027 days. A detailed descrip-
tion of the clinical signs was provided in an earlier report
[8]. Briefly, affected deer showed variable degrees of
ataxia, anorexia, circling and apparent blindness, together
with failure of seasonal change of coat, weight loss and
'panic attacks'. In addition, one of six red deer orally
dosed with BSE developed clinical disease 1740 days after
challenge, and this animal presented with a short clinical
duration of two days; the other five deer from this group
remain healthy at the time of writing (65 months after
challenge). Sequential rectal biopsies taken at five differ-
ent time points from orally and i.c. inoculated deer were
negative for PrPd.
All four deer orally challenged with CWD started to show
behavioural changes between 577 and 586 days post chal-
lenge; these progressed to definite neurological disease
between 742 and 760 days post-challenge (Table 1). Clin-
ical signs were similar to the BSE challenged deer and
included nervousness, weight loss, excessive salivation,
roughness of coat, and progressive ataxia. All these CWD-
inoculated deer showed PrPd accumulation in the second-
ary follicles of rectal biopsies taken at 7 months post-
infection.BMC Veterinary Research 2009, 5:26 http://www.biomedcentral.com/1746-6148/5/26
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Histopathology and IHC
Spongy change
In haematoxylin and eosin stained brain sections, spong-
iform change was widespread in all seven deer that devel-
oped clinical signs after BSE challenge regardless of the
route. Vacuolation was seen in the neuronal perikaryon
and neuropil of the brainstem, the molecular layer of the
cerebellum, the thalamus, and the layers V and VI of the
cerebral cortex (Fig 1). Spongy change was also observed
in the same brain areas of the CWD-challenged deer; in
these, intracytoplasmic vacuoles within neurones,
although present, were less prominent than in the BSE
challenged group. Otherwise no differences in pathologi-
cal features were identified between the two groups of
deer. Overall, spongiform changes and their distribution
were similar to those reported in cattle with BSE [21], in
sheep orally infected with BSE [22], and in CWD infected
mule deer and elk [23].
Accumulation of PrPd in the brain. Widespread diffuse
particulate labelling of the neuropil and intense intra-neu-
ronal accumulations of PrPd were observed throughout
the brains of BSE affected deer in sections labelled with
BAR224 antibody. Peri-neuronal labelling was prominent
in the dorsal motor nucleus of the vagus nerve (DMNV)
and in the corpus striatum. Intraneuronal granular accumu-
lations were prominent in nuclei of the medulla oblongata,
such as the accessory cuneate, spinal trigeminal and pos-
terior olivary, but were also present elsewhere in the brain
with the exception of Purkinje cells. Notably, there was
also intense labelling of the Golgi neurones in the granu-
lar cell layer of the cerebellum (Fig 2), which has not been
described in sheep or goat scrapie and which was absent
in the CWD infected deer. Slight differences in topograph-
ical distribution of PrPd  accumulation were observed
between the BSE affected deer: while five of the i.c. inocu-
lated animals showed abundant PrPd deposits in forebrain
areas, the single orally-challenged and one of the i.c. inoc-
ulated animals accumulated PrPd predominantly in the
brainstem and cerebellum, and very little elsewhere. This
last animal (deer 1 in table 1) was killed early in the clin-
ical phase of disease for welfare reasons, and this may
account for the lower overall magnitude of PrPd and for
the little involvement of forebrain areas. In contrast to the
BSE infected deer, the brains of CWD-affected animals
showed weak and inconsistent, fine punctate intra-neuro-
nal labelling mainly in neurons of the brainstem and of
the deep nuclei of the cerebellum. Like BSE cases, peri-
neuronal labelling was conspicuous in the DMNV; unlike
BSE cases, particulate and coalescing PrPd labelling in the
neuropil was prominent, with plaque like accumulations
seen throughout most brain areas, often associated with
white matter bundles and areas of conspicuous vacuola-
tion (Fig. 3).
Table 1: Experimental design and clinical data.
Inocula Route Deer
1 234 5 6
BSE I.C I.P 794 930 996 996 1060 1260
C.D 21 100 105 77 85 22
Oral I.P 1740
C.D 2
CWD Oral I.P 577 579 579 586
C.D 165 167 167 174
Deer numbers, routes of infection, incubation period (I.P) and clinical 
duration (C.D) in days.
BSE deer Figure 1
BSE deer. Vacuolation seen in the brainstem (a), the molec-
ular layer of the cerebellum (b), the thalamus (c), and layers 
V and VI of the cerebral cortex (d).
a  b
d  c
BSE deer Figure 2
BSE deer. Grey matter PrPd labelling of neuropil and intense 
perikaryonal labelling of a Golgi neuron in the granular cell 
layer of the cerebellum (arrow).BMC Veterinary Research 2009, 5:26 http://www.biomedcentral.com/1746-6148/5/26
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These differences in the patterns of PrPd accumulation
between BSE and CWD resulted in distinct PrPd profiles
that made subjective discrimination relatively straightfor-
ward (Figs. 4, 5). Further differences were evident when
evaluating the epitope mapping features of the PrPd mol-
ecules of both infections. Samples of obex and midbrain
were immunolabelled with N-terminal 12B2 antibody to
assess the magnitude of intra-neuronal PrPd signal in com-
parison with that obtained with BAR224. In BSE infected
deer, the intra-neuronal PrPd observed in almost all neu-
ronal populations with BAR224 was significantly reduced
or lost with 12B2 (Fig. 6), while in CWD affected animals,
the lower level of intra-neuronal PrPd  labelled with
BAR224 was nevertheless maintained with 12B2 (Fig. 7).
No significant difference in extra-cellular signal recovery
was seen between CWD and BSE when comparing results
with these N-terminal and globular domain antibodies.
Accumulation of PrPd outside the brain
In BSE inoculated deer, PrPd was detected in all segments
of the spinal cord, in autonomic ganglia, cranial and
peripheral nerves and in the sensory retina. Strong immu-
nolabelling was found in neurones throughout the enteric
nervous system, sometimes in close proximity to nearby
lymphoid follicles (Fig 8). However, the Peyer's patches,
and all other lymphoid tissues, were negative, as were all
other organs examined (for details see [8]). In contrast,
CWD infected deer were consistently PrPd positive in rec-
tal biopsies and in the retropharyngeal lymph node
(Fig 9).
Western blotting
The samples from red deer experimentally infected with
BSE, either orally or i.c., all gave molecular weight profiles
similar to those of cattle BSE, with a lower molecular
weight for the unglycosylated protein band compared to
that obtained for ovine scrapie, elk CWD or red deer CWD
CWD Deer Figure 3
CWD Deer. Vacuolation (oval) and diffuse PrPd accumula-
tion is present in the grey matter of the striatum of the brain. 
Focal intense plaque-like accumulations of PrPd (boxes) are 
also present.
 
IHC profile of PrPd types present in BSE infected deer  (green) and CWD infected deer (red) Figure 4
IHC profile of PrPd types present in BSE infected 
deer (green) and CWD infected deer (red). Profiles 
represent a single deer from each of the BSE and CWD 
infected groups. All six of the deer challenged i.c. with BSE 
and the single positive orally dosed deer presented consist-
ent profiles on subjective examination that were unlike those 
of the CWD infected deer. (ITNR, intraneuronal; ITAS, 
intra-astrocytic; ITMG, intra-microglial; STEL, stellate; SBPL, 
sub-pial; SBEP, sub-ependymal; PVRS, peri-vascular; PVAC, 
peri-vacuolar; PRCO, particulate coalescing; LINR, linear; 
PNER, perineuronal; VASC, vascular; EPEN, Ependymal).
0
1
2
3
ITNR ITAS ITMG STEL SBPL SBEP PRVS PVAC PRCO LINR PNER VASC EPEN
BSE and CWD deer Figure 5
BSE and CWD deer. Low magnification images (top) of 
midbrain highlight the marked differences seen between the 
predominantly intra-neronal and difuse particulate labelling of 
the neuropil that is seen in the BSE infected deer compared 
to the distinct coalescing plaque-like labelling in the CWD 
infected deer. The boxes outline the area shown at higher 
magnification in the lower two images.
     BSE      Midbrain       CWDBMC Veterinary Research 2009, 5:26 http://www.biomedcentral.com/1746-6148/5/26
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samples; the latter showed some degree of variability. The
antibody affinity was also different between BSE and
CWD infected deer. The former showed strong signal with
antibodies raised to the C-terminal region of the prion
protein (F99) and to globular domain (6H4 and Sha31)
and no signal with the antibodies raised to the N-terminus
of PrP (P4 and 12B2; Fig. 10), while this reactivity was
present in CWD infected animals (Fig. 11).
Discussion
Differences in attack rates and incubation periods
observed between oral cattle BSE (16%), intracerebral cat-
tle BSE (100%) and oral deer CWD (100%) included in
this study suggest that there is a strong species barrier
between cattle and deer in the case of BSE. Although it
needs to be pointed out that the remaining five deer orally
dosed are still alive and that infection cannot be ruled out,
this species barrier would agree with the low attack rate
found in intracerebral infections of cattle with the CWD
agent [24].
The examinations conducted on this experimental mate-
rial show that infections of red deer with BSE and at least
one source of CWD can be clearly differentiated by the
same laboratory methods previously used to discriminate
between BSE and scrapie in sheep [19,25,26] and goats.
Thus, the IHC epitope mapping approach shows that
intra-neuronal PrPd in BSE infected deer is truncated at an
BSE deer Figure 6
BSE deer. Comparison of intraneuronal labelling with 
BAR224 (C-terminal) and 12B2 (n-terminal) mAbs showing 
the significant loss of intraneuronal labelling with 12B2 in BSE 
infected deer in contrast to CWD infected deer. The extra-
cellular signal was maintained with 12B2 in both the CWD 
and BSE infected deer.
 BSE  BAR224   12B2  
CWD deer Figure 7
CWD deer. Comparison of intraneuronal labelling with 
BAR224 (C-terminal) and 12B2 (n-terminal) mAbs showing 
no reduction of the intracellular signal with the n-terminal 
targeting antibody.
 CWD  BAR224   12B2  
BSE deer Figure 8
BSE deer. Labelling of PrPd in cells of the myenteric (a) and 
sub-mucosal plexi (b) occurred in close proximity to negative 
Peyer's patches shown at high (b) and low magnification (c). 
Arrows show the capsule surrounding the same follicle.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c
b
aBMC Veterinary Research 2009, 5:26 http://www.biomedcentral.com/1746-6148/5/26
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epitope further towards the C terminus of the PrP mole-
cule than it does in CWD. This differential truncation also
takes place when exogenous enzymes are applied to brain
samples as indicated by the discriminatory WB results.
As for the subjectively assessed patterns of IHC PrPd accu-
mulation -the PrPd profile-, while these were highly con-
sistent amongst BSE infected deer, some variability was
observed in the CWD cases, with one deer showing a
slightly divergent profile to the other three and also a con-
siderably higher magnitude PrPd signal in all brain areas.
This variability was also observed in the electrophoretic
migration speed of PrPres in the red deer CWD samples, as
previously described for elk, mule deer and white tail deer
[27], raising the possibility that more than one phenotype
of CWD exists even amongst a limited number of animals.
Further work is required to investigate whether the IHC
profile and molecular weight variation seen in the red
deer CWD samples has any significance regarding strain
diversity, or is related to other as yet unidentified influ-
ences. We were able to examine the obex but not other
brain areas of each of the four elk that provided the
pooled inoculum for the CWD infected red deer, and the
distribution and patterns of PrPd observed in those sam-
ples were indistinguishable from those in the obex of the
CWD red deer recipients. Similarly, all four elk used in the
inoculum demonstrated almost identical molecular pro-
files, in contrast with the CWD recipient red deer where
some variability was observed. It is thus possible that the
host species may have an effect on molecular and patho-
logical phenotypes.
CWD Deer Figure 9
CWD Deer. Labelling of PrPd in tingible body macrophages 
(a) and follicular dendritic cells (b) within the secondary folli-
cle of a retropharyngeal lymph node.
 
b a
BSE deer Figure 10
BSE deer. Analysis of brain homogenates by Biorad TeSeE Western Blotting using F99, 6H4, SHA31, P4 and 12B2. Data is not 
shown for the last of the intracerebrally challenged group or for the single orally challenged BSE positive deer however these 
presented migration patterns and antibody affinities that were not significantly different from those seen above.
mAb 6H4
1    2  3  4    5  6   7    8    9   10   M
mAb12B2
1    2   3     4     5  6   7  8   9  10  M
mAb P4
1   2     3    4    5  6    7   8    9   10  M
mAbF99
1    2  3  4    5  6   7  8   9  10  M
mAbSHA31
1    2  3  4   5   6  7  8  9    10   M
KEY
1   Bovine BSE+ve
2   CWD  –ve
3   Natural CWD  +ve
4   Ovine Scrapie +ve
5   Cervine neg
6   Cervine BSE
7 Cervine BSE
8 Cervine BSE
9 Cervine BSE
10 Cervine BSE
M  Molecular marker
mkDa
m   kDa
mkDa
m kDa
mkDa
m   kDa
mkDa
m   kDa
mkDaBMC Veterinary Research 2009, 5:26 http://www.biomedcentral.com/1746-6148/5/26
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The minor differences in the topographical distribution of
PrPd found between the BSE orally and i.c. challenged deer
may be due to differences in the route of access of infectiv-
ity to the brain, as proposed for sheep infected with BSE
[12]. In this model, it has been shown that PrPd accumu-
lates in the porencephalic lesion resulting from the repair
process at the site of inoculation, and appears to spread to
other neighbouring areas of the cerebral cortex [28]. This
pathway would be absent in orally dosed animals,
explaining the lesser involvement of rostral areas of the
brain.
The fact that the circumventricular organs, which have
leaky capillaries and appear to be involved in the neuroin-
vasion process associated with infectivity present in blood
[29], were affected in these BSE infected deer adds support
to this notion.
PrPd was detected in the enteric nervous system and in
structures of the peripheral nervous system of the BSE
infected deer, regardless of the route of challenge. It is dif-
ficult to tell whether that peripheral PrPd accumulation
preceded neuroinvasion or resulted from centrifugal
spread, but the lack of LRS involvement in those same
deer rather supports the later possibility. This is unlikely
to be due to the i.c. route of challenge, as the only orally-
dosed deer succumbing to BSE was also negative for PrPd
in lymphoid tissues, and as lymphoid involvement has
been shown in BSE i.c. challenged sheep of several PRNP
genotypes [30]. The absence of LRS involvement seen in
BSE-affected red deer is more likely to respond to host
genetic factors, as it is reminiscent of cattle BSE, in which
the only documented evidence of LRS accumulation of
PrPd refers to Peyer's patches after experimental oral chal-
lenge [31], and of experimental BSE in sheep bearing the
ARR PRNP allele [29,30].
The absence of PrPd in LRS tissues of BSE affected deer, as
in natural cattle BSE, might be indicative of a low level of
circulating infectivity and suggests that BSE in deer may
not be contagious under conditions of natural exposure.
Conversely, red deer infected with CWD showed wide-
spread lymphoid involvement, which would be in agree-
ment with the highly contagious nature of this infection
in native North American cervids.
Conclusion
European red deer are susceptible to infection with the
cattle BSE agent, not only by the intra-cerebral but also by
the oral route, and although the clinical signs and spong-
CWD deer Figure 11
CWD deer. Analysis of brain homogenates by Biorad TeSeE Western Blotting using F99, 6H4, SHA31, P4 and 12B2. The 
molecular weights of samples from the four red deer experimentally infected with CWD were variable although all of them 
appeared higher than the cattle BSE control and are more consistent with the naturally infected CWD and scrapie controls.
mAb 6H4
M    1   2    3   4     5    6    7    8
mAb12B2
M    1    2    3   4     5  6   7  8
mAb P4
M   1   2         3   4     5   6    7    8
mAbF99
M   1    2    3   4     5    6    7    8
mAbSHA31
M   1     2    3   4     5    6    7    8
KEY
M Marker
1  Cervine CWD
2  Cervine CWD
3  Cervine CWD
4  Cervine CWD
5  Bovine BSE+ve
6  CWD -ve
7  Natural CWD +ve
8  Ovine Scrapie +ve
M Molecular marker
25 kDa →
15 kDa →
25 kDa →
15 kDa →
25 kDa →
15 kDa →
25 kDa →
15 kDa →
25 kDa →
15 kDa →BMC Veterinary Research 2009, 5:26 http://www.biomedcentral.com/1746-6148/5/26
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iform change are similar to those of CWD in the same spe-
cies, these two infections can be easily differentiated. The
lack of lymphoid involvement, the PrPd truncation pat-
tern both "in vivo" and "in vitro", and the predominantly
intracellular accumulation of PrPd are features of deer BSE
that are in contrast with those of deer CWD. However,
only one of six deer developed disease after alimentary
exposure to 25 g of a BSE brain pool homogenate after an
incubation period of nearly 5 years; this suggests a strong
species barrier but if a TSE in European red deer should
ever be identified then BSE/CWD discrimination would
be an urgent priority. To determine whether there are
potential naturally occurring BSE-like strains and to deter-
mine the degree to which there is strain variation, it would
be necessary to examine many more naturally occurring
CWD cases. These results will support the ongoing Euro-
pean surveillance for natural TSEs in red deer and the fur-
ther assessment of potential risk to human health.
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